Showing results (1471-1480 of 1,968) with videos related to
Sort By:
Pageof 197
Annals of Internal Medicine|April 1, 1981
Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal functionV W Horadam, J G Sharp, J D Smilack, et al.Plos One|June 1, 2011
Two naturally occurring terpenes, dehydrocostuslactone and costunolide, decrease intracellular GSH content and inhibit STAT3 activationElena Butturini, Elisabetta Cavalieri, Alessandra Carcereri de Prati, et al.BMC Geriatrics|January 17, 2016
The association of serum procalcitonin and high-sensitivity C-reactive protein with pneumonia in elderly multimorbid patients with respiratory symptoms: retrospective cohort studyAntonio Nouvenne, Andrea Ticinesi, Giuseppina Folesani, et al.Journal of Medicinal Chemistry|July 6, 2019
Virtual Screening Approach and Investigation of Structure-Activity Relationships To Discover Novel Bacterial Topoisomerase Inhibitors Targeting Gram-Positive and Gram-Negative PathogensGabriele Magarò, Federica Prati, Barbara Garofalo, et al.Nature|January 24, 2024
Nozaki-Bekki solitons in semiconductor lasersNikola Opačak, Dmitry Kazakov, Lorenzo L Columbo, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 3, 2022
The double injection technique to improve visualization of severe coronary lesions with optical coherence tomographyFernando Rivero, Valeria Marco, Flavio Giuseppe Biccirè, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 22, 2006
Animal model for liver cell banking from non-heart beating donors after prolonged ischaemia timeL Porretti, S Gatti, R Gramignoli, et al.Seminars in Arthritis and Rheumatism|August 25, 2011
New onset of uveitis during anti-tumor necrosis factor treatment for rheumatic diseasesDaniel Wendling, Julien Paccou, Jean-Marie Berthelot, et al.Cancer Biology & Therapy|January 17, 2004
Inhibition of cell survival and invasive potential of colorectal carcinoma cells by the tyrosine kinase inhibitor STI571Graziella Bellone, Dario Ferrero, Anna Carbone, et al.Lancet (London, England)|January 22, 2013
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trialMichael Haude, Raimund Erbel, Paul Erne, et al.Pageof 197